The Use of Recombinant Activated FVII (rFVIIa, Novoseven) in the Treatment of a Lifethreatening Retroperitoneal Hemorrhage in a Hemophilia A Patient with Inhibitors to FVIII

Diniz, MJDias, MFalcão, MTCruz, M2013-01-242013-01-242000IN: 16th International Congress on Thrombosis, 2000, 5 a 8 Mai. Porto, Portugalhttp://hdl.handle.net/10400.17/953engFactor VIIIFactor VIIaThe Use of Recombinant Activated FVII (rFVIIa, Novoseven) in the Treatment of a Lifethreatening Retroperitoneal Hemorrhage in a Hemophilia A Patient with Inhibitors to FVIIIother